Patients Discontinuing Weight-Loss Injections Put On Weight Far More Rapidly Than People Using Diet and Exercise

New research indicates that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional diet and exercise plans.

Research printed in a leading health publication points out that while obese people frequently drop about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.

"Individuals buying such medications should be informed of the risk of quick weight regain when the therapy ends," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery implies a return to original mass within about a year and a half.

Analyzing Treatments

The research, which reviewed dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with other pills.

Scientists note that individuals who lose weight through lifestyle changes alone usually see a slower weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Fast Regain

Doctors suggest the mode of action of the injections is key to understanding the heightened rebound.

The injections imitate a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating far more likely."

An Ongoing Condition?

Medical guidelines recommend the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, considering the high risk of weight regain, the treatment should be considered ongoing.

This opinion is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like high blood pressure.

Patient Testimonies

People who have discontinued the medication describe a powerful resurgence of hunger.

"It was like something activating and you're instantly starving," recalled a patient.

This challenge is worsened if users have not developed sustainable lifestyle or habit changes during therapy.

Widespread Interest

Survey data suggest that millions of people in the UK have tried these injections in the past year, with demand being substantial.

• Use is higher among females than males.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, experts caution that while the jabs are effective tools for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated behavioural management.